Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BSGMNASDAQ:CVRXNASDAQ:INGNNYSE:RBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSGMBiosig Technologies$8.32+16.5%$4.57$0.23▼$8.86$194.88M1.71348,176 shs1.07 million shsCVRXCVRx$6.04+2.7%$6.43$4.30▼$18.55$153.31M1.23317,413 shs128,668 shsINGNInogen$7.10+1.0%$6.64$5.70▼$13.33$189.02M1.66243,837 shs164,174 shsRBOTVicarious Surgical$7.34-2.1%$7.74$4.27▼$19.00$44.48M1.430,467 shs7,843 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSGMBiosig Technologies-6.79%-4.03%+33.96%+1,186.49%+1,939.42%CVRXCVRx+1.03%+2.80%-11.18%-53.07%-50.96%INGNInogen-0.71%+5.40%+9.16%+1.15%-13.53%RBOTVicarious Surgical+1.83%-5.35%-1.96%+17.65%+27.77%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSGMBiosig Technologies1.1676 of 5 stars2.50.00.00.02.20.80.6CVRXCVRx2.7105 of 5 stars3.41.00.00.02.34.20.6INGNInogen4.2921 of 5 stars3.34.00.03.91.51.71.3RBOTVicarious Surgical2.888 of 5 stars3.04.00.00.01.32.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSGMBiosig Technologies 3.00Buy$10.0020.19% UpsideCVRXCVRx 2.71Moderate Buy$14.50140.07% UpsideINGNInogen 2.50Moderate Buy$11.0054.93% UpsideRBOTVicarious Surgical 2.00Hold$9.2526.02% UpsideCurrent Analyst Ratings BreakdownLatest RBOT, BSGM, INGN, and CVRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/15/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/6/2025BSGMBiosig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$2.50 ➝ $10.005/22/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Moderate Buy$12.005/9/2025CVRXCVRxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.005/9/2025CVRXCVRxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.005/8/2025INGNInogenStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $7.004/21/2025BSGMBiosig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.75 ➝ $2.504/9/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/8/2025CVRXCVRxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $14.004/8/2025CVRXCVRxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $18.00(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSGMBiosig Technologies$40K5,678.40N/AN/A($0.09) per share-92.44CVRXCVRx$51.29M3.07N/AN/A$2.93 per share2.06INGNInogen$335.70M0.57N/AN/A$7.30 per share0.97RBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSGMBiosig Technologies-$10.33MN/A0.00N/AN/AN/A-5,336.99%-398.16%8/13/2025 (Estimated)CVRXCVRx-$59.97M-$2.18N/AN/AN/A-97.49%-79.04%-42.37%8/4/2025 (Estimated)INGNInogen-$35.89M-$1.15N/AN/AN/A-8.08%-14.76%-9.01%8/5/2025 (Estimated)RBOTVicarious Surgical-$63.22M-$10.45N/AN/AN/AN/A-120.53%-85.51%8/11/2025 (Estimated)Latest RBOT, BSGM, INGN, and CVRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025Q1 2025BSGMBiosig Technologies-$0.05-$0.14-$0.09-$0.14N/AN/A5/12/2025Q1 2025RBOTVicarious Surgical-$2.61-$2.58+$0.03-$2.60N/AN/A5/8/2025Q1 2025CVRXCVRx-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 million5/7/2025Q1 2025INGNInogen-$0.52-$0.25+$0.27-$0.25$79.57 million$82.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSGMBiosig TechnologiesN/AN/AN/AN/AN/ACVRXCVRxN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSGMBiosig TechnologiesN/A2.372.37CVRXCVRx0.7114.8213.45INGNInogenN/A3.072.67RBOTVicarious SurgicalN/A5.055.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSGMBiosig Technologies7.16%CVRXCVRx75.27%INGNInogen89.94%RBOTVicarious Surgical47.27%Insider OwnershipCompanyInsider OwnershipBSGMBiosig Technologies17.03%CVRXCVRx18.90%INGNInogen1.46%RBOTVicarious Surgical11.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSGMBiosig Technologies5027.30 million22.65 millionNo DataCVRXCVRx16026.07 million21.15 millionOptionableINGNInogen1,03026.89 million26.49 millionOptionableRBOTVicarious Surgical35.93 million5.22 millionNo DataRBOT, BSGM, INGN, and CVRX HeadlinesRecent News About These CompaniesVicarious Surgical Announces Election of New DirectorsJune 30 at 7:01 AM | businesswire.comHere's Why We're A Bit Worried About Vicarious Surgical's (NYSE:RBOT) Cash Burn SituationJune 18, 2025 | finance.yahoo.comGlucotrack, Inc. Appoints Dr. Victoria E. Carr-Brendel to Board of DirectorsMay 28, 2025 | quiverquant.comQVicarious Surgical Inc (RBOT) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...May 13, 2025 | gurufocus.comQ1 2025 Vicarious Surgical Inc Earnings Call TranscriptMay 12, 2025 | gurufocus.comVicarious Surgical inks surgical robot collab with hospital, eyes first clinical patientsMay 12, 2025 | massdevice.comVicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comVicarious Surgical Announces New Collaboration with UMass Memorial Medical CenterMay 12, 2025 | gurufocus.comVicarious Surgical Reports First Quarter 2025 Financial ResultsMay 12, 2025 | gurufocus.comVicarious Surgical Announces New Collaboration with UMass Memorial Medical CenterMay 12, 2025 | businesswire.comVicarious Surgical Reports First Quarter 2025 Financial ResultsMay 12, 2025 | businesswire.comWhy Vicarious Surgical Inc.’s (RBOT) Stock Is Up 11.04%April 29, 2025 | aaii.comAIntuitive wins FDA clearance for single-port robotic surgery staplerApril 11, 2025 | medtechdive.comMVicarious Surgical Receives Continued Listing Standard Notice from the NYSEApril 11, 2025 | gurufocus.comVicarious Surgical Receives Continued Listing Standard Notice from the NYSEApril 11, 2025 | businesswire.comVicarious Surgical president to transition to board roleMarch 25, 2025 | massdevice.comVicarious Surgical Announces President Transition to Board Member RoleMarch 24, 2025 | businesswire.comWhat Makes D8 (RBOT) a New Buy StockMarch 20, 2025 | zacks.comMonogram robot wins FDA OK; Vicarious hit by supplier woesMarch 19, 2025 | medtechdive.comMVicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 18, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRBOT, BSGM, INGN, and CVRX Company DescriptionsBiosig Technologies NASDAQ:BSGM$8.32 +1.18 (+16.53%) Closing price 04:00 PM EasternExtended Trading$8.46 +0.14 (+1.63%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.CVRx NASDAQ:CVRX$6.04 +0.16 (+2.72%) Closing price 04:00 PM EasternExtended Trading$5.90 -0.14 (-2.30%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Inogen NASDAQ:INGN$7.10 +0.07 (+1.00%) Closing price 04:00 PM EasternExtended Trading$7.12 +0.02 (+0.21%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Vicarious Surgical NYSE:RBOT$7.34 -0.16 (-2.13%) Closing price 03:58 PM EasternExtended Trading$7.32 -0.02 (-0.27%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
